# Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

> **NCT00378768** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 12 (estimated)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin

## Key facts

- **NCT ID:** NCT00378768
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378768, "Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00378768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*